Critics scoff that this sector lacks the prestige, competence and dedication other settings and players can offer. What a crock!
Why more long-term care operators are being nudged upstream
By
John O'Connor
Jun 12, 2022
There is continuing debate in long-term care about whether future success lies in upstream (increasingly healthcare focused) or downstream (increasingly service focused) services.
Do seniors even count?
By
John O'Connor
Oct 01, 2021
The knives are out, now that former New York Gov. Mario Cuomo (D) has resigned.
Some operators not clear on the ‘greatest asset’ concept
By
John O'Connor
May 24, 2021
“Our employees are our greatest asset.” How often have I heard that or a similar claim over the years?
PDPM: Here’s the rub
By
John O'Connor
Nov 14, 2019
If it seems like a lot of skilled nursing facility therapists have been getting laid off, it’s no coincidence. Genesis Healthcare grabbed the early lead in the pink slip parade. The firm let go of about...
What you really need to know about the presidential election
By
John O'Connor
Aug 22, 2016
Ignore the white noise over whether Hillary or The Donald will be a worse choice. There’s a sleeper issue in the November elections, and it just might have a major impact on your long-term care organization.
Changing the scenery
By
John O'Connor
Sep 04, 2015
The middle of July gave us quite a dose of ironic juxtaposition.
Labor nominee mum on card-check issue
By
John O'Connor
Feb 01, 2009
Senate Republicans grilled President Barack Obama’s choice for Labor secretary at a recent confirmation hearing. But Rep. Hilda L. Solis (D-CA) gave them little ammunition.
Trotting out a new therapy for those with Parkinson’s
By
John O'Connor
Dec 15, 2020
The Human Animal Bond Research Institute announced a new research project to see whether horses might be able to help reduce symptoms among people with Parkinson’s disease.
Study may lead to more effective drugs
By
John O'Connor
Nov 01, 2012
Researchers have discovered a previously unknown function for a protein that could add to the arsenal of inflammation-fighting drugs.